לבופר פלוס 125 ישראל - עברית - Ministry of Health

לבופר פלוס 125

teva pharmaceutical indust.ltd - benserazide as hydrochloride 25 mg; levodopa 100 mg - capsules - levodopa - for the relief of symptoms associated with parkinson's disease.

לבופר פלוס 250 ישראל - עברית - Ministry of Health

לבופר פלוס 250

teva pharmaceutical indust.ltd - benserazide as hydrochloride 50 mg; levodopa 200 mg - capsules - levodopa and decarboxylase inhibitor - for the relief of symptoms associated with parkinson's disease.

לבופר פלוס 250 ישראל - עברית - Ministry of Health

לבופר פלוס 250

teva pharmaceutical indust.ltd - benserazide as hydrochloride 50 mg; levodopa 200 mg - capsules - levodopa and decarboxylase inhibitor - for the relief of symptoms associated with parkinson's disease.

קומטן ® ישראל - עברית - Ministry of Health

קומטן ®

novartis pharma services ag - entacapone 200 mg - film coated tablets - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

קומטן  ישראל - עברית - Ministry of Health

קומטן

novartis israel ltd - entacapone - טבליות מצופות פילם - entacapone 200 mg - entacapone - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

רופינירול טבע   0.25 מג ישראל - עברית - Ministry of Health

רופינירול טבע 0.25 מג

teva pharmaceutical industries ltd, israel - ropinirole as hydrochloride - טבליות מצופות פילם - ropinirole as hydrochloride 0.25 mg - ropinirole - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רופינירול טבע  2 מג ישראל - עברית - Ministry of Health

רופינירול טבע 2 מג

teva pharmaceutical industries ltd, israel - ropinirole as hydrochloride - טבליות מצופות פילם - ropinirole as hydrochloride 2 mg - ropinirole - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

נאופרו 4 מ"ג / 24 שעות ישראל - עברית - Ministry of Health

נאופרו 4 מ"ג / 24 שעות

cts ltd - rotigotine 4 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

נאופרו 6 מ"ג / 24 שעות ישראל - עברית - Ministry of Health

נאופרו 6 מ"ג / 24 שעות

cts ltd - rotigotine 6 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

נאופרו 8 מ"ג / 24 שעות ישראל - עברית - Ministry of Health

נאופרו 8 מ"ג / 24 שעות

cts ltd - rotigotine 8 mg / 24 hour - patches - rotigotine - neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).